Phillips KA – Serotonin–reuptake inhibitors (SRIs or SSRIs) and cognitive behavioral therapy (CBT) are currently considered the first–line treatments for
body dysmorphic disorder (BDD). A practice guideline and a Cochrane review that recommend these treatments have been published, although treatment research on BDD is still quite limited.
The publication of these landmark documents underscores how important it is for clinicians to be knowledgeable about current treatment recommendations for BDD, which is a relatively common
and often disabling disorder that is associated with high morbidity and mortality.

Joyce PR et al. – Despite the two therapies having comparable efficacy in patients with depression, response to interpersonal psychotherapy (but not
cognitive–behavioural therapy) is affected by personality traits. This could suggest the two therapies are indicated for different patients or that they work by different
mechanisms.

Echeburua E et al. – Results of the repeated measurement analysis showed a significant increment in scores of Global Activity Functioning within the combined treatment
group during the follow–up, which was not observed in the control treatment group. Therefore, the effectiveness of psychotherapy tends to increase with time, and this improvement is
not significant until 12 months of follow–up.